Table 19, Phase 2 (Patients): Patients' Willingness to Tolerate Side Effects If It Meant They Might Live Longer - How Do Preferences for Treatment Change After Patients With Lung Cancer Start Chemotherapy?

	Variable	Category	No. (%)
First interview (N = 235)	Willingness to tolerate	Yes	166 (70.6)
No	25 (10.6)
Don't know	44 (18.8)
Last interview (N = 168)^a	Willingness to tolerate	Yes	114 (67.9)
No	16 (9.5)
Don't know	38 (22.6)
Change	Change in the willingness to tolerate between first and last interview	Yes	56 (33.3)
No	112 (66.7)

From: How Do Preferences for Treatment Change After Patients With Lung Cancer Start Chemotherapy?

Cover of How Do Preferences for Treatment Change After Patients With Lung Cancer Start Chemotherapy?

How Do Preferences for Treatment Change After Patients With Lung Cancer Start Chemotherapy? [Internet]

Islam KM, Ganti AK, Ryan J, et al.

Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2020 Feb.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License which permits noncommercial use and distribution provided the original author(s) and source are credited. (See https://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Table 19Phase 2 (Patients): Patients' Willingness to Tolerate Side Effects If It Meant They Might Live Longer